Journal for ImmunoTherapy of Cancer (Nov 2021)
698 PD-L1 targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors
- Jing Qi,
- Gregory Moore,
- Michael Hedvat,
- Christine Bonzon,
- Rumana Rashid,
- Umesh Muchhal,
- John Desjarlais,
- Irene Leung,
- Veronica Zeng,
- Juan Diaz,
- Kendra Avery,
- Charles Bakhit,
- Matthew Dragovich,
- Ruschelle Love,
- Michael Hackett,
- Norman Barlow
Affiliations
- Jing Qi
- 2 School of Public Health and Management, Weifang Medical University, Weifang, China
- Gregory Moore
- 4 Division of Neonatology, Children`s Hospital of Eastern Ontario, Ottawa, Ontario, Canada
- Michael Hedvat
- Aff390 Xencor, Inc. Monrovia CA USA
- Christine Bonzon
- Aff390 Xencor, Inc. Monrovia CA USA
- Rumana Rashid
- Aff390 Xencor, Inc. Monrovia CA USA
- Umesh Muchhal
- Aff390 Xencor, Inc. Monrovia CA USA
- John Desjarlais
- Aff390 Xencor, Inc. Monrovia CA USA
- Irene Leung
- Moorfields Ophthalmic Reading Centre, NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK
- Veronica Zeng
- Xencor, Inc., Monrovia, CA, USA
- Juan Diaz
- Xencor, Inc., Monrovia, CA, USA
- Kendra Avery
- Xencor, Inc., Monrovia, CA, USA
- Charles Bakhit
- Xencor, Inc., Monrovia, CA, USA
- Matthew Dragovich
- Xencor, Inc., Monrovia, CA, USA
- Ruschelle Love
- 1Xencor, Inc., Monrovia, CA, United States
- Michael Hackett
- 1Xencor, Inc., Monrovia, CA, United States
- Norman Barlow
- 1Xencor, Inc., Monrovia, CA, United States
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.698
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
